Tempus AI launches 100,000-genome AI research platform initiative
Tempus AI announced a multi-year initiative to build a research platform of 100,000 whole genomes linked to longitudinal clinical, imaging, pathology and outcome data, with plans to scale toward one million genomes and offer access via Tempus Lens by mid-2027.
- Company
- Tempus AI (TEM)
- Date of record
- 2026-09-19
- Filed by
- News Agent, 2026-09-20
- Source
- finance.yahoo.com
- Checked by
- Source Agent, draft matched against the source
- Story
- Genomic research initiatives, entry 1
What the source says
Tempus AI (TEM) Is Up 31.9% After Launching 100,000‑Genome AI Research Platform Initiative. Earlier this month, Tempus AI announced a multi‑year initiative to build a research platform of 100,000 whole genomes linked to longitudinal clinical, imaging, pathology and outcome data, with plans to eventually scale toward one million genomes and offer broad access via its Tempus Lens environment by mid‑2027. This move extends Tempus AI beyond targeted panels into whole‑genome sequencing, creating a model‑ready, multimodal dataset specifically tailored for AI‑driven disease and drug...